Voyager Therapeutics, Inc. (VYGR) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Voyager Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -1.93x | -5.03x | 2.74x | -5.04x | -1.43x | 7.23x |
| P/B Ratio | 1.18x | 1.09x | 1.54x | 3.96x | 1.07x | 1.72x |
| P/S Ratio | 5.71x | 4.09x | 1.45x | 5.72x | 2.73x | 1.55x |
| Profitability | ||||||
| Gross Margin | 100.0% | 100.0% | 63.1% | -36.3% | -97.2% | 36.4% |
| Operating Margin | -326.6% | -104.1% | 48.8% | -124.3% | -196.8% | 16.0% |
| Net Margin | -296.5% | -81.3% | 52.9% | -113.4% | -190.3% | 21.5% |
| EBITDA Margin | -316.5% | -98.2% | 50.6% | -96.9% | -183.0% | 18.2% |
| Liquidity | ||||||
| Current Ratio | 7.64x | 5.56x | 4.96x | 1.72x | 2.68x | 7.39x |
| Quick Ratio | 7.64x | 5.56x | 4.96x | 1.72x | 2.68x | 7.39x |
| Leverage | ||||||
| Debt/Equity | 0.19x | 0.15x | 0.09x | 0.39x | 0.46x | 0.31x |
YoY = year-over-year change. Source: FMP..